TrialAnnals of oncology : official journal of the European Society for Medical Oncology2015

Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA.

I E Krop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.